Daito Pharmaceutical Co., Ltd. — Investor Relations & Filings
Filings indexed
76
across all filing types
Latest filing
2022-04-14
Interim / Quarterly Rep…
Country
JP
Japan
Listing
T
4577
Daito Pharmaceutical Co., Ltd. is a manufacturer specializing in the integrated production of pharmaceuticals, from active pharmaceutical ingredients (APIs) to finished formulation products. The company's core activities include the development and supply of APIs, primarily for generic drugs, and the manufacturing of generic and over-the-counter (OTC) medications. Additionally, Daito provides contract manufacturing services for various pharmaceutical products. The company emphasizes a comprehensive quality assurance system to ensure the stable supply of high-quality products to its clients.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 四半期報告書－第80期第3四半期(令和3年12月1日－令和4年2月28日) | 2022-04-14 | Japanese | |
| 四半期報告書－第80期第2四半期(令和3年9月1日－令和3年11月30日) | 2022-01-14 | Japanese | |
| 四半期報告書－第80期第1四半期(令和3年6月1日－令和3年8月31日) | 2021-10-14 | Japanese | |
| 確認書 | 2021-08-26 | Japanese | |
| 内部統制報告書－第79期(令和2年6月1日－令和3年5月31日) | 2021-08-26 | Japanese | |
| 有価証券報告書－第79期(令和2年6月1日－令和3年5月31日) | 2021-08-26 | Japanese |
Browse filings by year
12 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2022
2 filings
| |||||
| 7611167 | 四半期報告書－第80期第3四半期(令和3年12月1日－令和4年2月28日) | 2022-04-14 | Japanese | ||
| 7619177 | 四半期報告書－第80期第2四半期(令和3年9月1日－令和3年11月30日) | 2022-01-14 | Japanese | ||
|
2021
6 filings
| |||||
| 7625475 | 四半期報告書－第80期第1四半期(令和3年6月1日－令和3年8月31日) | 2021-10-14 | Japanese | ||
| 7626834 | 確認書 | 2021-08-26 | Japanese | ||
| 7626832 | 内部統制報告書－第79期(令和2年6月1日－令和3年5月31日) | 2021-08-26 | Japanese | ||
| 7626835 | 有価証券報告書－第79期(令和2年6月1日－令和3年5月31日) | 2021-08-26 | Japanese | ||
| 7672871 | 四半期報告書－第79期第3四半期(令和2年12月1日－令和3年2月28日) | 2021-04-14 | Japanese | ||
| 7678285 | 四半期報告書－第79期第2四半期(令和2年9月1日－令和2年11月30日) | 2021-01-14 | Japanese | ||
|
2020
6 filings
| |||||
| 7683055 | 四半期報告書－第79期第1四半期(令和2年6月1日－令和2年8月31日) | 2020-10-14 | Japanese | ||
| 7684297 | 確認書 | 2020-08-28 | Japanese | ||
| 7684298 | 内部統制報告書－第78期(令和1年6月1日－令和2年5月31日) | 2020-08-28 | Japanese | ||
| 7684301 | 有価証券報告書－第78期(令和1年6月1日－令和2年5月31日) | 2020-08-28 | Japanese | ||
| 7691391 | 四半期報告書－第78期第3四半期(令和1年12月1日－令和2年2月29日) | 2020-04-14 | Japanese | ||
| 7694984 | 四半期報告書－第78期第2四半期(令和1年9月1日－令和1年11月30日) | 2020-01-14 | Japanese | ||
|
2019
1 filing
| |||||
| 7698602 | 四半期報告書－第78期第1四半期(2019/06/01－2019/08/31) | 2019-10-11 | Japanese | ||
Market data
Market data not available
Last price
Market cap
volume
Day range
today
52-week range
trailing
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
13260917 Canada Inc.
Biotech developing oral small molecules to restore muscle s…
|
MSCL | CA | Manufacturing |
|
1608557 Ontario Inc.
Biopharmaceutical company dedicated to R&D, discovery, and …
|
OTROQ | CA | Manufacturing |
|
3B BlackBio Dx Limited
Develops molecular diagnostic kits for oncology, infectious…
|
3BBLACKBIO | IN | Manufacturing |
|
3D Medicines Inc.
Commercial-stage biopharma specializing in next-generation …
|
1244 | HK | Manufacturing |
|
3SBio Inc.
Biopharmaceutical enterprise specializing in R&D, productio…
|
1530 | KY | Manufacturing |
|
4BASEBIO PLC
Manufactures GMP-grade synthetic DNA for next-generation th…
|
4BB | GB | Manufacturing |
|
4D Molecular Therapeutics, Inc.
Develops genetic medicines using AAV vectors for ophthalmol…
|
FDMT | US | Manufacturing |
|
4Front Ventures Corp.
Vertically integrated cannabis operator managing cultivatio…
|
FFNT | CA | Manufacturing |
|
4SC AG
Biopharmaceutical company with no products under developmen…
|
VSC | DE | Manufacturing |
|
60 DEGREES PHARMACEUTICALS, INC.
Develops and commercializes medicines for infectious diseas…
|
SXTP | US | Manufacturing |
Daito Pharmaceutical Co., Ltd. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/13603/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=13603 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=13603 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
Full reference: API reference · OpenAPI schema
cURL
$ curl https://api.financialreports.eu/api/filings/?company=13603 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 13603}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Daito Pharmaceutical Co., Ltd. (id: 13603)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.
We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.